Cocrystal Pharma Inc (NAS:COCP)
$ 2.0655 -0.0345 (-1.64%) Market Cap: 21.01 Mil Enterprise Value: 10.22 Mil PE Ratio: 0 PB Ratio: 1.65 GF Score: 36/100

Cocrystal Pharma Inc Annual Shareholders Meeting Transcript

May 18, 2022 / 06:00PM GMT
Release Date Price: $4.68 (-0.46%)
James Martin
Cocrystal Pharma, Inc. - Interim Co-CEO and CFO

Good afternoon, and welcome to the 2022 annual meeting of Cocrystal Pharma, Inc. My name is James Martin, and I am the Co-Interim Chief Executive Officer, Chief Financial Officer, and Secretary of the Company, as well as Chairman of this meeting. As Chairman, under our bylaws, I have set both the agenda for this meeting, which you should be able to see on your computer screen, and certain operating procedures to provide for the orderly transaction of business.

You should be able to see a link to our meeting procedures in the corner of your screen. This is our annual meeting, and we are holding it as a virtual-only meeting as permitted by the law of the State of Delaware, our state of incorporation.

Also present at the meeting are Dr. Sam Lee, our Co-Interim Chief Executive Officer and President. Also joining us today are Constantine Christakis and Michael Harris of Nason, Yeager, Gerson, Harris & Fumero, P.A., our Corporate Counsel. Dr. Lee will act as Secretary of this meeting. Mr. Christakis will be appointed to act as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot